Early Supported Discharge After Stroke in Bergen
Early Supported Discharge After Stroke in Bergen. An RCT Looking at the Collaboration Between Hospital Service and Primary Health Care.
The main purpose of this study is to evaluate the benefit of early supported discharge (ESD) in rehabilitation of stroke patients in two different outpatient modalities.
In a collaborating study, changes in physical function as well as the patients' own perception of physical function, pain and fatigue will be studied. In further collaborating studies, health economics and organizational issues will also be evaluated.
Study Overview
Status
Conditions
Detailed Description
Early supported discharge (ESD) seems to be at least as effective as hospital rehabilitation after stroke, and possibly better. In this study patients with recent stroke will be randomized to one of three different treatment arms:
- ESD with treatment at a day institution until 4 hrs. per day for up to 5 weeks
- ESD with treatment in the patients' home until 4 hrs. per day for up to 5 weeks
- Rehabilitation treatment "as usual", with a longer hospital stay, but without any specific treatment or follow-up after discharge
The patients in the two ESD arms will in addition be followed closely by a multidisciplinary coordinating team during the stay in hospital and the 5 week period of treatment after discharge, and they will be offered follow-ups at 3 and 6 months after inclusion into the study.
Patients in all 3 arms will be systematically examined with a set of measuring instruments as well as objective physical and function tests. This will be performed at inclusion and at 3, 6, 12 and 24 months after inclusion.
In the collaborating study by physiotherapist Bente Gjelsvik a comparison between changes in trunk control, balance, walking and ADL 3 months post stroke, as well as the patients' perceptions of physical function, pain and fatigue, will be the main focus. To assess function, functional change and possible differences between different interventions, there is a need for reliable and valid outcome measures. As a basis for the use of the outcome measure Trunk Impairment Scale (TIS) in this study, the TIS has been translated into Norwegian, Trunk Impairment Scale - Norwegian version (TIS-NV) and will be examined for measurement properties using data from the above study as well as data from patients with brain damage recruited from the Department of Physical Rehabilitation Medicine, Haukeland University Hospital. An examination of a possible connection between localisation and size of the stroke and trunk control will also be performed, as characteristics of the stroke may have therapeutic implications for the choice of intervention for the individual patient. The research questions for the planned doctoral thesis for Bente Gjelsvik are therefore as follows:
- Is the TIS-NV reliable and valid in patients with brain damage?
- Are changes in trunk control, balance, walking and daily activities, as well as pain and fatigue 3 months post stroke different in patients who have received interventions from different courses of rehabilitation in the study "Early supported discharge after stroke in Bergen"? To which degree do the patients perceive problems related to balance, physical activity, walking, pain and fatigue?
- Is there a correlation between localization and size of the stroke as measured by magnetic tomography, and the patients' trunk control? Are initial localization and size of the stroke predictive for the patients' trunk control 3 months post stroke?
Another collaborating project is carried out by PhD candidate Hedda Døli (Language outcome after stroke: lesion location, prognosis and consequences).
The aim of her first study in the PhD project is to investigate the relationship between lesion location and aphasia severity one week post-stroke. Thereafter a follow-up study of the same patients 12 months post-stroke investigates the prognosis of aphasia and the variables that may influence recovery. In the third study the aim is to investigate the health-related quality of life and the occurrence of depression in patients with aphasia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bergen, Norway, N-5021
- Haukeland University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Living in own home in the community of Bergen, Norway
- Inclusion within 1-7 days (24-168 hours) after debut of symptoms
- Inclusion within 6-120 hours after admission to Department of Neurology
- NIHSS score 2-26 at inclusion OR NIHSS score < 2 if Modified Rankin Scale is 2 or higher when being 0 before the stroke
- The patient must be awake and informed consent must be given by patient or relatives
Exclusion Criteria:
- Serious psychic illness
- Serious drug abuse
- Serious medical conditions that can influence the patients' cerebrovascular disease or rehabilitation
- Poor knowledge of the Norwegian language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Day unit rehabilitation
Discharge from the hospital to the patients' homes as soon as possible, supported by an out-patient ambulatory coordinating multidisciplinary team.
The patients will be offered rehabilitation in a day unit, and multidisciplinary policlinical follow-ups will be performed 3 and 6 months after inclusion.
|
Treatment by physiotherapist and occupational therapist up to 4 hours a day for up to 5 weeks in a day unit
|
|
Active Comparator: Home rehabilitation
Discharge from the hospital to the patients' homes as soon as possible, supported by an out-patient ambulatory coordinating multidisciplinary team.
The patients will be offered rehabilitation treatment in their homes, and multidisciplinary policlinical follow-ups will be performed 3 and 6 months after inclusion.
|
Treatment by physiotherapist and occupational therapist up to 4 hours a day for up to 5 weeks in the patient's home
|
|
No Intervention: Treatment as usual
Patients will receive rehabilitation treatment after today's principles and routines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRS
Time Frame: 6 months
|
Modified Rankin Scale
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NIHSS
Time Frame: 3, 6 and 12 months
|
National Institutes of Health Stroke Scale
|
3, 6 and 12 months
|
|
BI
Time Frame: 3, 6, 12 and 24 months
|
Barthel ADL Index
|
3, 6, 12 and 24 months
|
|
AMPS
Time Frame: 3 and 6 months
|
Assessment of Motor and Process Skills
|
3 and 6 months
|
|
TIS
Time Frame: 3 and 6 months
|
Trunk Impairment Scale
|
3 and 6 months
|
|
SIS
Time Frame: 12 months
|
Stroke Impact Scale
|
12 months
|
|
RSS
Time Frame: 12 months
|
Relative Stress Scale
|
12 months
|
|
PGIC
Time Frame: 12 and 24 months
|
Patients' Global Impression of Change
|
12 and 24 months
|
|
SF-36
Time Frame: 12 and 24 months
|
Short Form (36) Health Survey
|
12 and 24 months
|
|
MRS
Time Frame: 3, 12 and 24 months
|
Modified Rankin Scale
|
3, 12 and 24 months
|
|
PASS (Postural Assessment Scale for Stroke)
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
|
5mTW (5 meter Timed Walk)
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
|
TUG (Timed Up and Go)
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
|
NRS (Numeric Rating Scale)
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
|
Norwegian Basic Test for Aphasia
Time Frame: 3 and 12 months
|
3 and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jan S. Skouen, PhD, Haukeland University Hospital
Publications and helpful links
General Publications
- Hofstad H, Naess H, Moe-Nilssen R, Skouen JS. Early supported discharge after stroke in Bergen (ESD Stroke Bergen): a randomized controlled trial comparing rehabilitation in a day unit or in the patients' homes with conventional treatment. Int J Stroke. 2013 Oct;8(7):582-7. doi: 10.1111/j.1747-4949.2012.00825.x. Epub 2012 May 18.
- Gjelsvik B, Breivik K, Verheyden G, Smedal T, Hofstad H, Strand LI. The Trunk Impairment Scale - modified to ordinal scales in the Norwegian version. Disabil Rehabil. 2012;34(16):1385-95. doi: 10.3109/09638288.2011.645113. Epub 2011 Dec 23.
- Hofstad H, Gjelsvik BE, Naess H, Eide GE, Skouen JS. Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual. BMC Neurol. 2014 Dec 21;14:239. doi: 10.1186/s12883-014-0239-3.
- Gjelsvik BE, Hofstad H, Smedal T, Eide GE, Naess H, Skouen JS, Frisk B, Daltveit S, Strand LI. Balance and walking after three different models of stroke rehabilitation: early supported discharge in a day unit or at home, and traditional treatment (control). BMJ Open. 2014 May 14;4(5):e004358. doi: 10.1136/bmjopen-2013-004358.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18993
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.